Loading...

Canopy Growth Corporation

CGCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.14
$0.03(2.70%)

Canopy Growth Corporation (CGC) Stock Overview

Explore Canopy Growth Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 58.5/100

Key Financials

Market Cap235.7M
P/E Ratio-0.20
EPS (TTM)$-4.13
ROE-1.13%
Fundamental Analysis

AI Price Forecasts

1 Week$1.55
1 Month$0.54
3 Months$0.49
1 Year Target$0.74

CGC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Canopy Growth Corporation (CGC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.20 and a market capitalization of 235.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;